APA

Royakkers A. A. N. M., Korevaar J. C., van Suijlen J. D. E., Hofstra L. S., Kuiper M. A., Spronk P. E., Schultz M. J. & Bouman C. S. C. (20110712). Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. : Intensive care medicine.

Chicago

Royakkers Annick A N M, Korevaar Johanna C, van Suijlen Jeroen D E, Hofstra Lieuwe S, Kuiper Michael A, Spronk Peter E, Schultz Marcus J and Bouman Catherine S C. 20110712. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. : Intensive care medicine.

Harvard

Royakkers A. A. N. M., Korevaar J. C., van Suijlen J. D. E., Hofstra L. S., Kuiper M. A., Spronk P. E., Schultz M. J. and Bouman C. S. C. (20110712). Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. : Intensive care medicine.

MLA

Royakkers Annick A N M, Korevaar Johanna C, van Suijlen Jeroen D E, Hofstra Lieuwe S, Kuiper Michael A, Spronk Peter E, Schultz Marcus J and Bouman Catherine S C. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. : Intensive care medicine. 20110712.